This week’s New England deals list includes a mix of life sciences and IT companies.
—Lexington, MA-based T2 Biosystems, a developer of a system for identifying biological substances such as proteins, small molecules, viruses, and DNA more cheaply and quickly than existing methods, took in $23 million in Series D financing. New T2 investor Aisling Capital led the round, which also included return backers Flagship Ventures, Polaris Venture Partners, Flybridge Capital Partners, Physic Ventures, Partners Healthcare, Arcus Ventures, RA Capital, Camros Capital, and WS Investments.
—Boston-based online data storage firm Carbonite raised $62.5 million in an initial public offering, selling 6.25 million shares at $10 per share. That was the bottom end of a range ($10 to $11) that Carbonite (NASDAQ: [[ticker:CARB]]) had already lowered earlier on the day it priced. Late last month it had said it expected to price the shares at $15 to $17 each.
—My colleague Greg wrote about how Harvard University’s Office of Technology Development is looking to raise another fund of $20 to $30 million, up from its $10 million “Accelerator Fund,” created to help the school’s scientists commercialize their inventions.
—Amesbury, MA-based Fluidnet, a maker of electronic infusion pumps for administering IV fluids, raised $19.8 million of an offering that could hit $25 million, according to an SEC filing.
—Proteon Therapeutics, a Waltham, MA-based kidney and vascular drug developer, nabbed $15.2 million from 19 investors, an SEC filing showed.
—Lexington-based Pulmatrix raised $14 million in Series B financing, to bring its total funding raised to $60 million. The investment came
